MedTrace Logo

Isometric Exercise for Delayed Onset Muscle Soreness

NCT07627152 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 40

Last updated 2026-06-16

No results posted yet for this study

Summary

The goal of this clinical trial is to learn whether isometric exercise can improve recovery following experimentally induced delayed onset muscle soreness (DOMS) in healthy young adults.

The main questions it aims to answer are:

* Does isometric exercise reduce pain associated with delayed onset muscle soreness?
* Does isometric exercise improve pressure pain threshold, knee joint range of motion, muscle strength, and recovery following delayed onset muscle soreness?

Researchers will compare participants performing an isometric exercise program with a control group receiving no intervention to determine whether isometric exercise improves recovery after experimentally induced DOMS.

Participants will:

* Undergo a standardized exercise protocol to induce delayed onset muscle soreness.
* Be randomly assigned to either an isometric exercise group or a control group.
* Complete assessments of pain intensity, pressure pain threshold, knee range of motion, muscle strength, and thigh circumference.
* Be evaluated before exercise, immediately after exercise, and on Days 1, 3, and 5 following DOMS induction.

Conditions

  • Delayed Onset Muscle Soreness (DOMS)

Interventions

OTHER

Isometric Exercise

Participants performed a structured quadriceps isometric exercise program following experimentally induced delayed onset muscle soreness. The exercise protocol was applied according to the study protocol throughout the recovery period.

OTHER

Sham Exercise

Participants performed a sham exercise protocol following experimentally induced delayed onset muscle soreness. The sham intervention was designed to mimic the attention and participation associated with the experimental intervention without providing the intended therapeutic effect.

Sponsors & Collaborators

  • Istanbul Nisantasi University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
30 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-07-18
Completion
2025-07-18

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07627152 on ClinicalTrials.gov